Sugi Predict

Sugi Predict / Compounds / SCHEMBL1523060

SCHEMBL1523060

SCHEMBL1523060

O=c1oc(=O)n(Cc2ccccc2)c2nnc(Cl)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 4/20 0.44
▸ CD74 P04233 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ KDM4A O75164 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ IDO1 P14902 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522698 0.75 PTGDR2 (0.51) MIFALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL1522428 0.74 ADORA1 (0.46) MIFCD74ALDH1A1KDM4EHPGD
SCHEMBL26124443 0.72 IDO1 (0.57) MIFCD74NPC1IDO1MAPT
SCHEMBL5535346 0.72 IDO1 (0.54) MIFCD74NPC1IDO1KMT2A
SCHEMBL1522607 0.72 MIF (0.66) MIFCD74NPC1ALDH1A1KDM4E
SCHEMBL7324840 0.70 MIF (0.55) MIFCD74NPC1ALDH1A1IDO1
SCHEMBL12659782 0.70 SRC (0.49) MIFALDH1A1KDM4EHPGDTSHR
SCHEMBL1522402 0.69 PTGDR2 (0.55) ALDH1A1KDM4EHPGDHTTIDO1
SCHEMBL1522600 0.69 MAPT (0.43) ALDH1A1KDM4ERECQLMAPT
SCHEMBL9371190 0.69 MIF (0.71) MIFCD74NPC1IDO1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361913-A1 Anti-infective agents Abbott Laboratories (US) 2011-08-31 — — EP disclosed
US-7902203-B2 Anti-infective agents ABBOTT LABORATORIES, INC. (US) 2011-03-08 — — US disclosed
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 — — EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 — — US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 — — US disclosed
US-20040097492-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-20 — — US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097492-A1 Anti-infective agents POLR1C, RPL5, POLB MIF 1032/4885CD74 399/4885NPC1 468/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB MIF 1032/4885CD74 399/4885NPC1 468/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT MIF 243/4885CD74 236/4885NPC1 174/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB MIF 1032/4885CD74 399/4885NPC1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.